Skip to main content
Skip to section navigation
Skip to footer
Back to AchieveLifeSciences.com
Investor Relations
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Contacts
Financial Info
Overview
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Whistleblower Information
All SEC Filings
SEC Filings
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10QSB
3
4
4/A
424B2
424B3
424B4
424B5
424B7
425
5
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFC14A
DEFM14A
DEL AM
EFFECT
FWP
NT 10-K
NTN 10K
POS AM
PRE 14A
PREC14A
PREM14A
PRER14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
Date
Form
Description
PDF
XBRL
Pages
01/11/23
EFFECT
Notice of Effectiveness
1
01/05/23
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
2
01/04/23
UPLOAD
SEC-generated letter
Documents
expand_more
TEXT-EXTRACT
1
01/03/23
S-3/A
Registration statement for specified transactions by certain issuers
Documents
expand_more
EX-23.2
8
12/30/22
DEL AM
Separately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statement
1
12/29/22
S-3
Registration statement for specified transactions by certain issuers
Documents
expand_more
EX-5.1
EX-23.2
EX-FILING FEES
29
12/08/22
D/A
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
11/29/22
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
11/28/22
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
9
11/25/22
8-K
Current report filing
3
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
…
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
Page
14
Page
15
Page
16
Page
17
…
…
Page
123
Next Page
arrow_forward
Email Alerts
Contacts
RSS News Feed